本实验利用透析袋平衡透析、毛细管电泳Ru(bpy)3^2+电化学发光检测技术测定了丙吡胺和人血浆蛋白的结合率。在恒电位1.3V;进样电压10kV持续10s,分离电压15kV,运行缓冲液30mmol/L磷酸盐缓冲液(pH7.5),检测池中为5mmoL/LRu(bpy)3^2+稀释于50mmol/L磷酸盐缓冲液(pH7.5)中等最优化的条件下,丙吡胺的检出限为10μmoL/L(S/N=3)。对蛋白结合率的测定结果表明,人血浆中的药物浓度为1.6-8.2mmol/L,丙吡胺与血浆蛋白的结合是呈线性的,其线性回归方程为y=-0.07+0.93x,线性相关系数r为0.9999,丙吡胺与人血浆蛋白的结合率约为90.4%。
The binding rate of disopyramide with human plasma protein was determined using capillary electrophoresis(CE) coupled with tris(2,2'-bipyridyl) ruthenium( Ⅱ ) [ Ru(bpy)3^2+ ] electrochemiluminescence (ECL) detection after equilibrium dialysis. Under optimal conditions( ECL detection at 1.3 V, electrokinetically injection at 10 kV for 10 s, 15 kV as the separation voltage, 30 mmol/L phosphate buffer at pH 7.5 as running buffer and 5 mmoL/L Ru(bpy)3^2+ in 50 mmol/L phosphate buffer at pH 7.5 in the detection cell) , the detection limit of disopyramide was 10 μmoL/L(S/N = 3 ). The results of protein binding indicated that the binding of disopyramide with plasma protein was linear with a correlation coefficient of 0. 9999 when the ranges of concentration of disopyramide in plasma were 1.6 -8.2 retool/L, and the human plasma protein binding rate of disopyramide was 90.4%.